amikacin: activity observations

294 observations · Complete record (JSON.gz)

Observations 201–294 of 294

Activity observations
Organism	Activity	MIC	Disk diffusion	Assay	Strain	Sample/genome	Evidence
Mycobacterium tuberculosis complex	RESISTANT	2.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	23 source isolates 23 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	4.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	22 source isolates 22 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	8.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	20 source isolates 20 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	<=0.25 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	6184 source isolates 6184 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	>16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	257 source isolates 257 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	—	—	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	5 source isolates 5 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	0.5 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	4 source isolates 4 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	3 source isolates 3 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	<=0.25 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	4 source isolates 4 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	>16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	8 source isolates 8 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	—	—	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	1 source isolates 1 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	0.5 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	1 source isolates 1 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	1 source isolates 1 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	<=0.25 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	5 source isolates 5 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	>16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	3 source isolates 3 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	—	—	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	1 source isolates 1 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	0.5 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	322 source isolates 322 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	1.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	24 source isolates 24 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	4 source isolates 4 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	2.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	1 source isolates 1 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	<=0.25 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	540 source isolates 540 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	>16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	7 source isolates 7 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	0.5 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	575 source isolates 575 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	1.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	109 source isolates 109 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	22 source isolates 22 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	2.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	24 source isolates 24 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	4.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	7 source isolates 7 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	8.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	12 source isolates 12 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	<=0.25 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	669 source isolates 669 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	>16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	4 source isolates 4 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	—	—	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	22 source isolates 22 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	0.5 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	21 source isolates 21 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	1.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	4 source isolates 4 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	2.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	5 source isolates 5 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	8.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	2 source isolates 2 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	<=0.25 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	61 source isolates 61 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	>16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	1 source isolates 1 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	—	—	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	4 source isolates 4 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	0.5 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method MB; reading day 14	—	30 source isolates 30 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	1.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method MB; reading day 14	—	10 source isolates 10 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method MB; reading day 14	—	2 source isolates 2 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	2.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method MB; reading day 14	—	2 source isolates 2 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	<=0.25 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method MB; reading day 14	—	11 source isolates 11 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	>16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method MB; reading day 14	—	6 source isolates 6 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	0.5 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	34 source isolates 34 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	1.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	1 source isolates 1 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	1 source isolates 1 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	2.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	4 source isolates 4 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	4.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	2 source isolates 2 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	<=0.25 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	293 source isolates 293 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	—	—	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	5 source isolates 5 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	0.5 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	145 source isolates 145 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	1.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	45 source isolates 45 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	18 source isolates 18 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	2.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	5 source isolates 5 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	4.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	5 source isolates 5 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	8.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	6 source isolates 6 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	<=0.25 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	238 source isolates 238 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	>16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 14	—	71 source isolates 71 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	0.5 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method MB; reading day 21	—	34 source isolates 34 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	1.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method MB; reading day 21	—	11 source isolates 11 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	2.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method MB; reading day 21	—	2 source isolates 2 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	<=0.25 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method MB; reading day 21	—	5 source isolates 5 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	>16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method MB; reading day 21	—	11 source isolates 11 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	0.5 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	21 source isolates 21 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	1 source isolates 1 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	<=0.25 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	32 source isolates 32 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	—	—	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	16 source isolates 16 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	0.5 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	32 source isolates 32 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	1.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	11 source isolates 11 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	3 source isolates 3 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	2.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	5 source isolates 5 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	8.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	1 source isolates 1 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	SUSCEPTIBLE	<=0.25 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	92 source isolates 92 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	RESISTANT	>16.0 mg/L	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	16 source isolates 16 measurements	Evidence Page data (JSON.gz)
Mycobacterium tuberculosis complex	—	—	—	CRyPTIC UKMYC UKMYC6; primary method VZ; reading day 21	—	1 source isolates 1 measurements	Evidence Page data (JSON.gz)
Klebsiella pneumoniae NCBITaxon:573	—	16.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	0497	BioSample SAMN11953783	Evidence Page data (JSON.gz)
Escherichia coli NCBITaxon:562	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	0346	BioSample SAMN11953774	Evidence Page data (JSON.gz)
Klebsiella pneumoniae NCBITaxon:573	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	1153	BioSample SAMN34111340	Evidence Page data (JSON.gz)
Pseudomonas aeruginosa NCBITaxon:287	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	1155	BioSample SAMN34111341	Evidence Page data (JSON.gz)
Pseudomonas aeruginosa NCBITaxon:287	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	1156	BioSample SAMN34111342	Evidence Page data (JSON.gz)
Pseudomonas aeruginosa NCBITaxon:287	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	1157	BioSample SAMN34111343	Evidence Page data (JSON.gz)
Klebsiella pneumoniae NCBITaxon:573	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	1158	BioSample SAMN34111344	Evidence Page data (JSON.gz)
Pseudomonas aeruginosa NCBITaxon:287	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	1159	BioSample SAMN34111345	Evidence Page data (JSON.gz)
Pseudomonas aeruginosa NCBITaxon:287	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	1161	BioSample SAMN34111347	Evidence Page data (JSON.gz)
Klebsiella pneumoniae NCBITaxon:573	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	1163	BioSample SAMN34111349	Evidence Page data (JSON.gz)
Pseudomonas aeruginosa NCBITaxon:287	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	1268	BioSample SAMN33435241	Evidence Page data (JSON.gz)
Pseudomonas aeruginosa NCBITaxon:287	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	1269	BioSample SAMN33435242	Evidence Page data (JSON.gz)
Pseudomonas aeruginosa NCBITaxon:287	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	1270	BioSample SAMN33435243	Evidence Page data (JSON.gz)
Pseudomonas aeruginosa NCBITaxon:287	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2025 M100 S35.	1328	BioSample SAMN50502207	Evidence Page data (JSON.gz)
Acinetobacter baumannii NCBITaxon:470	—	>64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2020 M100 S30 per the CDC/FDA AR Isolate Bank Panel 1227 footnote.	0083	BioSample SAMN04014924	Evidence Page data (JSON.gz)
Acinetobacter baumannii NCBITaxon:470	—	64.0 mg/L	—	Broth microdilution amikacin MIC; modal MIC reported; interpreted using CLSI 2024 M100 S34 per the CDC/FDA AR Isolate Bank Panel 1227 footnote.	0078	BioSample SAMN04014919	Evidence Page data (JSON.gz)
Pseudomonas aeruginosa NCBITaxon:287	—	>64.0 mg/L	—	CDC/FDA AR Isolate Bank amikacin MIC; interpreted using CLSI 2026 M100 Ed36 per the Panel 1394 footnote.	1332	—	Evidence Page data (JSON.gz)
Pseudomonas aeruginosa NCBITaxon:287	—	>64.0 mg/L	—	CDC/FDA AR Isolate Bank amikacin MIC; interpreted using CLSI 2026 M100 Ed36 per the Panel 1394 footnote.	1333	—	Evidence Page data (JSON.gz)